Skip to main content
logo
Sagimet Biosciences Inc. (SGMT)
NASDAQ: SGMT · Real-Time Price · USD
10.65
-0.18 (-1.66%)
Nov 10, 2026, 10:33 AM EST - Market open

Sagimet Biosciences Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
755193145124--
Market Cap Growth
208.79%32.89%16.75%---
Enterprise Value
50067-2522--
Last Close Price
10.835.924.505.42--

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
---62.05--
PB Ratio
2.611.730.931.36--
P/TBV Ratio
3.001.730.931.36--

EV Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
EV/Sales Ratio
---11.18--

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.010.000.000.000.010.01
Net Debt / Equity Ratio
-1.00-1.01-1.02-1.04-1.16-1.00
Asset Turnover
---0.03--
Quick Ratio
44.3122.1833.9616.786.1323.25
Current Ratio
45.0322.8234.3017.096.2124.04
Return on Equity (ROE)
-24.37%-38.20%-36.92%-46.96%-72.58%-39.63%
Return on Assets (ROA)
-16.41%-25.70%-26.49%-29.62%-42.16%-23.16%
Return on Capital Employed (ROCE)
-20.40%-51.10%-35.00%-33.80%-111.90%-41.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-11.73%-26.51%-31.45%-22.46%--
Buyback Yield / Dilution
-17.03%-3.17%-199.71%-5565.90%-50.61%-26.95%
SEC Filings: 10-K · 10-Q